Geode Capital Management’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-45,429
| Closed | -$17K | – | 4181 |
|
|
2020
Q1 | $17K | Hold |
45,429
| – | – | ﹤0.01% | 4047 |
|
|
2019
Q4 | $18K | Hold |
45,429
| – | – | ﹤0.01% | 4170 |
|
|
2019
Q3 | $90K | Hold |
45,429
| – | – | ﹤0.01% | 3971 |
|
|
2019
Q2 | $98K | Buy |
45,429
+11,631
| +34% | +$29.7K | ﹤0.01% | 3968 |
|
|
2019
Q1 | $106K | Hold |
33,798
| – | – | ﹤0.01% | 3886 |
|
|
2018
Q4 | $84K | Hold |
33,798
| – | – | ﹤0.01% | 3895 |
|
|
2018
Q3 | $135K | Hold |
33,798
| – | – | ﹤0.01% | 3867 |
|
|
2018
Q2 | $126K | Buy |
+33,798
| New | +$88.2K | ﹤0.01% | 3830 |
|
|
2017
Q4 | – | Sell |
-18,731
| Closed | -$40K | – | 4052 |
|
|
2017
Q3 | $40K | Buy |
18,731
+6,493
| +53% | +$22.1K | ﹤0.01% | 3964 |
|
|
2017
Q2 | $55K | Sell |
12,238
-1,488
| -11% | -$5.4K | ﹤0.01% | 3940 |
|
|
2017
Q1 | $41K | Buy |
13,726
+546
| +4% | +$1.61K | ﹤0.01% | 3979 |
|
|
2016
Q4 | $36K | Buy |
13,180
+364
| +3% | +$1.04K | ﹤0.01% | 3954 |
|
|
2016
Q3 | $40K | Buy |
12,816
+91
| +0.7% | +$332 | ﹤0.01% | 3938 |
|
|
2016
Q2 | $65K | Hold |
12,725
| – | – | ﹤0.01% | 3886 |
|
|
2016
Q1 | $52 | Sell |
12,725
-91
| -0.7% | -$487 | ﹤0.01% | 3962 |
|
|
2015
Q4 | $103K | Buy |
+12,816
| New | +$107K | ﹤0.01% | 3877 |
|
Geode Capital Management's CORV Position: Q2 2020 in Review
Geode Capital Management sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q2 2020, closing a stake of 45,429 shares — an estimated $17K sold.
Geode Capital Management first reported a position in CORV in Q4 2015 and held it in 16 quarters. The position peaked at $135K in Q3 2018. 0 funds tracked by Wall St. Rank hold CORV as of Q2 2020.
- Geode Capital Management reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q2 2020 after selling out during the quarter.
- Geode Capital Management sold 45,429 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q2 2020, an estimated $17K.
- Geode Capital Management first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q4 2015 and held it in 16 quarters.
- Geode Capital Management's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $135K in Q3 2018.
- 0 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q2 2020.
Based on Geode Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.